JPRN-jRCT2080220313未知3 期
Clinical study to evaluate the efficacy and safety of TA-650 in patients with psoriasis
适应症
试验速览
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 16age old 至 ot applicable（—）
- 性别
- All
入选标准
- •[Inclusion criteria]
- •Psoriasis patients who are candidates for phototherapy or systemic therapy, 16 years and above, male and female.
- •[Exclusion criteria]
- •Patients who, have previously used any anti-TNFalpha therapy, have a history of serious infection which caused hospitalization within 6 months before the registration, have an active tuberculosis, have a complication or a history of malignancy within 5 years before the registration.
排除标准
- 未提供
研究者
相似试验
已完成
3 期
result of vitimelin tablet and vitimelin oil in vitiligoCTRI/2021/04/033014DrVasishths Ayuremedies30
已完成
2 期
A study for Under eye dark circlesCTRI/2022/09/045732Transformative Learning Solutions Pvt Ltd32
进行中（未招募）
不适用
Clinical study to evaluate the efficacy and safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in adults. - N/AEUCTR2005-003552-35-DEOctapharma AG116
已完成
2 期
Clinical study on Dabur gel in reduction of oral malodor.CTRI/2021/07/034750Dabur India limited161
进行中（未招募）
不适用
Clinical study to evaluate the efficacy and safety of Octagam® 10% in Idiopathic Thrombocytopenic Purpura in adults. - N/AIdiopathic thrombocytopenic purpura, in adults actively bleeding or at high risk bleeding.MedDRA version: 7.0Level: LLTClassification code 10021245EUCTR2005-003552-35-ATOctapharma AG116